We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

116 hedge funds and large institutions have $698M invested in Editas Medicine in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 16

42% more capital invested

Capital invested by funds: $490M → $698M (+$207M)

42% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 26

5% more funds holding

Funds holding: 110 → 116 (+6)

1.64% less ownership

Funds ownership: 70.65% → 69.01% (-1.6%)

30% less call options, than puts

Call options by funds: $6.76M | Put options by funds: $9.71M

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
116
Holders Change
+6
Holders Change %
+5.45%
% of All Funds
2.89%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
24
Increased
37
Reduced
26
Closed
16
Calls
$6.76M
Puts
$9.71M
Net Calls
-$2.94M
Net Calls Change
-$6.9M

Top Buyers

1
State Street
State Street
Massachusetts
+$25M
2
GTP
Global Thematic Partners
New York
+$10.8M
3
Invesco
Invesco
Georgia
+$6.31M
4
American Century Companies
American Century Companies
Missouri
+$5.94M
5
NI
Numeric Investors
Massachusetts
+$5.14M

Top Sellers

1
FP
Flagship Pioneering
Massachusetts
-$32.4M
2
PVMCV
Polaris Venture Management Co VI
Massachusetts
-$19M
3
EC
EcoR1 Capital
California
-$12M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.41M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$109M -$4.41M -231,525 -5%
BlackRock
2
BlackRock
New York
$63.4M +$2.03M +106,894 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$55.1M +$2.28M +119,609 +5%
State Street
4
State Street
Massachusetts
$44.5M +$25M +1,314,284 +244%
PVMCV
5
Polaris Venture Management Co VI
Massachusetts
$43.1M -$19M -1,000,002 -36%
Capital World Investors
6
Capital World Investors
California
$42.5M – – –
DM
7
Deerfield Management
New York
$41M – – –
Viking Global Investors
8
Viking Global Investors
Connecticut
$41M – – –
FP
9
Flagship Pioneering
Massachusetts
$40.2M -$32.4M -1,701,749 -50%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$29.7M -$4.29M -225,389 -15%
AIM
11
ARK Investment Management
Florida
$16.5M +$3.38M +177,683 +35%
GTP
12
Global Thematic Partners
New York
$13.6M +$10.8M +565,041 New
Morgan Stanley
13
Morgan Stanley
New York
$13.5M +$1.93M +101,236 +22%
Northern Trust
14
Northern Trust
Illinois
$9.05M +$68.4K +3,593 +1%
Millennium Management
15
Millennium Management
New York
$8.97M +$3.97M +208,773 +127%
Goldman Sachs
16
Goldman Sachs
New York
$8.12M +$1.23M +64,820 +24%
Invesco
17
Invesco
Georgia
$7.96M +$6.31M +331,547 New
American Century Companies
18
American Century Companies
Missouri
$7.5M +$5.94M +312,229 New
TCIM
19
TIAA CREF Investment Management
New York
$6.62M +$2.4M +125,969 +84%
NI
20
Numeric Investors
Massachusetts
$6.49M +$5.14M +270,200 New
GIM
21
Granahan Investment Management
Massachusetts
$5.8M +$305K +15,999 +7%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$5.73M -$881K -46,283 -16%
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$5M +$703K +36,927 +22%
GAM
24
Greenwoods Asset Management
Cayman Islands
$4.37M +$2.11M +111,000 +156%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$4.04M +$497K +26,093 +18%
1
2 3 4 5

EDIT Hedge Fund Activity: Q3 2017 in Review

116 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2017, worth a combined $698M — up 42% from $490M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 16 closed out — a net gain of 8 holders — while 37 added to existing stakes and 26 trimmed.

The largest buyer was State Street, adding an estimated $25M. The largest seller was Flagship Pioneering, cutting an estimated $32.4M.

  • 116 institutional investors held Editas Medicine (EDIT) as of Q3 2017, up from 110 in Q2 2017.
  • Funds reported $698M of Editas Medicine stock for Q3 2017, up 42% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2017 and 16 closed out, a net change of +8 holders.
  • The largest Editas Medicine buyer in Q3 2017 was State Street, an estimated $25M added.
  • The largest Editas Medicine seller in Q3 2017 was Flagship Pioneering, an estimated $32.4M sold.

Based on aggregated 13F filings for Q3 2017.